AxoSim is founded in 2014, operates from its headquarter in 1441 Canal Street New Orleans, LA 70112, US. The company operates in the Business Services, Research & Development sector.
AxoSim specializes in Human neuroscience, Neurological disease research, Drug discovery, Peripheral neuropathy, Neuropathic pain, ALS disease modeling, MS disease modeling, CMT disease modeling, Neurotoxicology, and offers services including NerveSim®, BrainSim®, and microBrain™.
Total Rounds
US$ 3.7M
Last Round
US$ 3.7M
Rounds
1